Literature DB >> 15537882

M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity.

Thomas Seeger1, Irina Fedorova, Fang Zheng, Tsuyoshi Miyakawa, Elena Koustova, Jesus Gomeza, Anthony S Basile, Christian Alzheimer, Jürgen Wess.   

Abstract

Muscarinic acetylcholine receptors are known to play key roles in facilitating cognitive processes. However, the specific roles of the individual muscarinic receptor subtypes (M1-M5) in learning and memory are not well understood at present. In the present study, we used wild-type (M2+/+) and M2 receptor-deficient (M2-/-) mice to examine the potential role of M2 receptors in learning and memory and hippocampal synaptic plasticity. M2-/- mice showed significant deficits in behavioral flexibility and working memory in the Barnes circular maze and the T-maze delayed alternation tests, respectively. The behavioral deficits of M2-/- mice were associated with profound changes in neuronal plasticity studied at the Schaffer-CA1 synapse of hippocampal slices. Strikingly, short-term potentiation (STP) was abolished, and long-term potentiation (LTP) was drastically reduced after high-frequency stimulation of M2-/- hippocampi. Treatment of M2-/- hippocampal slices with the GABA(A) receptor antagonist, bicuculline, restored STP and significantly increased LTP. Whole-cell recordings from CA1 pyramidal cells demonstrated a much stronger disinhibition of GABAergic than glutamatergic transmission in M2-/- hippocampi, which was particularly prominent during stimulus trains. Increased strength of GABAergic inhibition is thus a likely mechanism underlying the impaired synaptic plasticity observed with M2-/- hippocampi. Moreover, the persistent enhancement of excitatory synaptic transmission in CA1 pyramidal cells induced by the transient application of a low concentration of a muscarinic agonist (referred to as LTP(m)) was totally abolished in M2-/- mice. Because impaired muscarinic cholinergic neurotransmission is associated with Alzheimer's disease and normal aging processes, these findings should be of considerable therapeutic relevance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15537882      PMCID: PMC6730182          DOI: 10.1523/JNEUROSCI.3581-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.709


  54 in total

Review 1.  Molecular genetic analysis of synaptic plasticity, activity-dependent neural development, learning, and memory in the mammalian brain.

Authors:  C Chen; S Tonegawa
Journal:  Annu Rev Neurosci       Date:  1997       Impact factor: 12.449

2.  Different sensitivities to agonist of muscarinic acetylcholine receptor subtypes.

Authors:  H Bujo; J Nakai; T Kubo; K Fukuda; I Akiba; A Maeda; M Mishina; S Numa
Journal:  FEBS Lett       Date:  1988-11-21       Impact factor: 4.124

Review 3.  A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice.

Authors:  J N Crawley; R Paylor
Journal:  Horm Behav       Date:  1997-06       Impact factor: 3.587

Review 4.  Advances and limitations of the molecular neuroanatomy of cholinergic receptors: the example of multiple muscarinic receptors.

Authors:  M T Vilaró; G Mengod; J M Palacios
Journal:  Prog Brain Res       Date:  1993       Impact factor: 2.453

Review 5.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

Review 6.  Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests.

Authors:  J N Crawley
Journal:  Brain Res       Date:  1999-07-17       Impact factor: 3.252

7.  Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in CA1 of the hippocampus and the associated improvement in working memory.

Authors:  J M Daniel; G P Dohanich
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

8.  Antisense oligodeoxynucleotides against the muscarinic m2, but not m4, receptor supports its role as autoreceptors in the rat hippocampus.

Authors:  K Kitaichi; T Hori; L K Srivastava; R Quirion
Journal:  Brain Res Mol Brain Res       Date:  1999-04-06

9.  Muscarinic acetylcholine receptor subtype, m2: diverse functional implications of differential synaptic localization.

Authors:  S T Rouse; T M Thomas; A I Levey
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

10.  Effect of scopolamine and nootropic drugs on rewarded alternation in a T-maze.

Authors:  L Bartolini; R Risaliti; G Pepeu
Journal:  Pharmacol Biochem Behav       Date:  1992-12       Impact factor: 3.533

View more
  75 in total

1.  Palmitic acid methyl ester is a novel neuroprotective agent against cardiac arrest.

Authors:  Reggie Hui-Chao Lee; Alexandre Couto E Silva; HarLee E Possoit; Francesca M Lerner; Po-Yi Chen; Rinata Azizbayeva; Cristiane T Citadin; Celeste Yin-Chieh Wu; Jake T Neumann; Hung Wen Lin
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2018-11-23       Impact factor: 4.006

2.  M2 muscarinic acetylcholine receptors regulate long-term potentiation at hippocampal CA3 pyramidal cell synapses in an input-specific fashion.

Authors:  Fang Zheng; Jürgen Wess; Christian Alzheimer
Journal:  J Neurophysiol       Date:  2012-04-04       Impact factor: 2.714

Review 3.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

4.  Muscarinic receptor activation enables persistent firing in pyramidal neurons from superficial layers of dorsal perirhinal cortex.

Authors:  Vicky L Navaroli; Yanjun Zhao; Pawel Boguszewski; Thomas H Brown
Journal:  Hippocampus       Date:  2011-09-28       Impact factor: 3.899

Review 5.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

6.  Muscarinic excitation of parvalbumin-positive interneurons contributes to the severity of pilocarpine-induced seizures.

Authors:  Feng Yi; Evan DeCan; Kurt Stoll; Eric Marceau; Karl Deisseroth; J Josh Lawrence
Journal:  Epilepsia       Date:  2014-12-13       Impact factor: 5.864

7.  Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities.

Authors:  Xiangyou Hu; Qi Shi; Xiangdong Zhou; Wanxia He; Hong Yi; Xinghua Yin; Marla Gearing; Allan Levey; Riqiang Yan
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

8.  Modulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in mice.

Authors:  Morgane Thomsen; Jürgen Wess; Brian S Fulton; Anders Fink-Jensen; S Barak Caine
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

9.  Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks.

Authors:  F E Harrison; A H Hosseini; M P McDonald
Journal:  Behav Brain Res       Date:  2008-10-18       Impact factor: 3.332

10.  Presynaptic m1 muscarinic receptors are necessary for mGluR long-term depression in the hippocampus.

Authors:  Ariel Kamsler; Thomas J McHugh; David Gerber; Shu Ying Huang; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.